The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials
Introduction Statins may reduce the severity of psoriasis, but the available evidence is unclear. We conducted a meta-analysis of randomized controlled studies (RCTs) that investigated the effect of statins on psoriasis severity assessed with the Psoriasis Area and Severity Index (PASI). Material a...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Termedia Publishing House
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a9bf09405f2f4b459cbdc46f9aefed23 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:a9bf09405f2f4b459cbdc46f9aefed23 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:a9bf09405f2f4b459cbdc46f9aefed232021-12-02T16:59:26ZThe effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials1734-19221896-915110.5114/aoms.2019.90343https://doaj.org/article/a9bf09405f2f4b459cbdc46f9aefed232019-12-01T00:00:00Zhttps://www.archivesofmedicalscience.com/The-effect-of-statins-on-psoriasis-severity-a-meta-analysis-of-randomized-clinical,113177,0,2.htmlhttps://doaj.org/toc/1734-1922https://doaj.org/toc/1896-9151Introduction Statins may reduce the severity of psoriasis, but the available evidence is unclear. We conducted a meta-analysis of randomized controlled studies (RCTs) that investigated the effect of statins on psoriasis severity assessed with the Psoriasis Area and Severity Index (PASI). Material and methods Two investigators searched independently the following databases: Medline, EMBASE, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov from inception to February 2019. Additionally, reference lists from all available articles were searched manually. We included only RCTs carried out among adult (≥ 16 years) patients with psoriasis who received oral statins for ≥ 8 weeks and had psoriasis severity assessed with the PASI at baseline and at the end of follow-up. We used random effects meta-analysis to calculate the mean difference (D) in PASI change between patients who received either a statin or a comparator. Results Of 279 records identified, there were 5 eligible RCTs, with a total of 223 patients, including 128 patients who received a statin (atorvastatin or simvastatin). The improvement in psoriasis severity (PASI) was significantly greater in patients who received statins than in those who received comparators (D = 2.76, 95% CI: 0.49–5.04, p = 0.017). In subgroup analyses, the improvement in PASI values was significant for simvastatin (D = 3.70, 95% CI: 2.52–4.89, p < 0.001) but not for atorvastatin (D = 2.30, 95% CI: –1.28–5.88, p = 0.210). Conclusions Oral statins may improve psoriasis, particularly in patients with severe disease. This observation should be verified in long-term, well-designed studies that will enable analyses adjusted for clinical variables.Mateusz SochaAldona PietrzakEwelina GrywalskaDaniel PietrzakDariusz MatosiukPaweł KicińskiJacek RolinskiTermedia Publishing Housearticlehydroxymethylglutaryl-coa reductase inhibitorspsoriasissimvastatinatorvastatinMedicineRENArchives of Medical Science, Vol 16, Iss 1, Pp 1-7 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
hydroxymethylglutaryl-coa reductase inhibitors psoriasis simvastatin atorvastatin Medicine R |
| spellingShingle |
hydroxymethylglutaryl-coa reductase inhibitors psoriasis simvastatin atorvastatin Medicine R Mateusz Socha Aldona Pietrzak Ewelina Grywalska Daniel Pietrzak Dariusz Matosiuk Paweł Kiciński Jacek Rolinski The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials |
| description |
Introduction
Statins may reduce the severity of psoriasis, but the available evidence is unclear. We conducted a meta-analysis of randomized controlled studies (RCTs) that investigated the effect of statins on psoriasis severity assessed with the Psoriasis Area and Severity Index (PASI).
Material and methods
Two investigators searched independently the following databases: Medline, EMBASE, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov from inception to February 2019. Additionally, reference lists from all available articles were searched manually. We included only RCTs carried out among adult (≥ 16 years) patients with psoriasis who received oral statins for ≥ 8 weeks and had psoriasis severity assessed with the PASI at baseline and at the end of follow-up. We used random effects meta-analysis to calculate the mean difference (D) in PASI change between patients who received either a statin or a comparator.
Results
Of 279 records identified, there were 5 eligible RCTs, with a total of 223 patients, including 128 patients who received a statin (atorvastatin or simvastatin). The improvement in psoriasis severity (PASI) was significantly greater in patients who received statins than in those who received comparators (D = 2.76, 95% CI: 0.49–5.04, p = 0.017). In subgroup analyses, the improvement in PASI values was significant for simvastatin (D = 3.70, 95% CI: 2.52–4.89, p < 0.001) but not for atorvastatin (D = 2.30, 95% CI: –1.28–5.88, p = 0.210).
Conclusions
Oral statins may improve psoriasis, particularly in patients with severe disease. This observation should be verified in long-term, well-designed studies that will enable analyses adjusted for clinical variables. |
| format |
article |
| author |
Mateusz Socha Aldona Pietrzak Ewelina Grywalska Daniel Pietrzak Dariusz Matosiuk Paweł Kiciński Jacek Rolinski |
| author_facet |
Mateusz Socha Aldona Pietrzak Ewelina Grywalska Daniel Pietrzak Dariusz Matosiuk Paweł Kiciński Jacek Rolinski |
| author_sort |
Mateusz Socha |
| title |
The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials |
| title_short |
The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials |
| title_full |
The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials |
| title_fullStr |
The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials |
| title_full_unstemmed |
The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials |
| title_sort |
effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials |
| publisher |
Termedia Publishing House |
| publishDate |
2019 |
| url |
https://doaj.org/article/a9bf09405f2f4b459cbdc46f9aefed23 |
| work_keys_str_mv |
AT mateuszsocha theeffectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT aldonapietrzak theeffectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT ewelinagrywalska theeffectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT danielpietrzak theeffectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT dariuszmatosiuk theeffectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT pawełkicinski theeffectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT jacekrolinski theeffectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT mateuszsocha effectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT aldonapietrzak effectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT ewelinagrywalska effectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT danielpietrzak effectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT dariuszmatosiuk effectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT pawełkicinski effectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials AT jacekrolinski effectofstatinsonpsoriasisseverityametaanalysisofrandomizedclinicaltrials |
| _version_ |
1718382286386233344 |